Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, May 23, 2023.
Abbott recently released significant data backing the use of its Aveir dual-chamber leadless pacemaker. This data provides valuable insights into the device’s performance, efficacy, and safety. Fast Five hosts Sean Whooley and Danielle Kirsh dive into the details of the study, examining the key findings and their implications for patients who may benefit from this advanced pacemaker technology.
Moving on to Boston Scientific, which has shared positive data on two of its notable devices: Farapulse and Watchman FLX. The data supporting Farapulse demonstrates its potential in treating specific cardiac conditions, and the positive data for Watchman FLX highlights its effectiveness as a left atrial appendage closure device. Whooley explores these findings in detail, discussing how they contribute to the evolving landscape of cardiovascular care.
A recent study from Philips suggests that artificial intelligence could predict ventricular tachycardia or arrhythmia. The study showcases the potential of AI algorithms to analyze complex patient data and provide early detection and intervention for this condition. Kirsh and Whooley examine the study methodology, discuss the implications of integrating AI into cardiac care, and explore the future possibilities it holds for improving patient outcomes.
Vicarious Surgical has promoted John Mazzola to the position of chief operating officer. Mazzola’s experience and contributions to the company have been instrumental in its growth and success. As COO, he will play a role in overseeing and optimizing the company’s operations, driving innovation, and further advancing its surgical robotic platform. Whooley takes a closer look at Mazzola’s background, the significance of this promotion, and the strategic direction of Vicarious Surgical moving forward.
The Fast Five hosts share positive data from Medtronic’s Harmony transcatheter pulmonary valve. The positive data from their recent study demonstrates the effectiveness and durability of this innovative device in treating patients with congenital heart defects. We’ll explore the purpose of the study, the implications of the positive results, and how the Harmony valve offers a minimally invasive solution with improved outcomes for patients in need.
Subscribe to the Fast Five daily news podcast on your preferred listening platform. If you’re on a desktop computer, scan the QR code below with your smartphone to easily access the podcast on your mobile device.
Listen to previous episodes here.